Skip to content

Anant Vatsayan, MBBS

NPI 1780991414ActiveIndividual· Pediatrics, Pediatric Hematology-Oncology· Washington, DC

Pediatrics, Pediatric Hematology-Oncology (MBBS) in Washington, District of Columbia, licensed in DC, with an NPI issued in September 2010. Part D covered 11 prescriptions written in 2024, 100% of them generic. Adaptive Biotechnologies Corporation was the largest of 3 companies reporting payments in 2025, $1,318 in all, mostly travel and lodging.

Overview

NPI1780991414
StatusActive
Entity typeIndividual
CredentialMBBS
Sole proprietorNo
NPI issuedSep 1, 2010
Last updated in NPPESJun 11, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Hematology-Oncology Primary2080P0207XMD047284DC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (DC)

Part D prescriptions in 2024

Prescriptions (claims)11 · 11 30-day fills
Total drug cost$112.11
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,318 · 8 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Travel and Lodging$1,024 · 4 payments
  • Food and Beverage$294.26 · 4 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Hematology-Oncology providers in Washington

All 61 Pediatrics, Pediatric Hematology-Oncology providers in Washington · All Pediatrics, Pediatric Hematology-Oncology providers in District of Columbia